Tranexamic acid use during total hip arthroplasty
Established
29
Citations96
Refs2018
Year
Search Works
Work Details
- DOI 10.1097/md.0000000000010720
- PMID https://pubmed.ncbi.nlm.nih.gov/29794747
- PMCID https://www.ncbi.nlm.nih.gov/pmc/articles/6392984
- OpenAlex ID W2803583232
- Type Article
- Language EN
- Published 01 May 2018
- Volume 97 (21)
- Pages e10720
- Source Medicine
- Publisher Wolters Kluwer
- FWCI 2.06
- Countries 1
- Institutions 4
- Added 01 Jun 2018
- Updated 28 Oct 2026
External Links
MENU
0
Tranexamic acid use during total hip arthroplasty
Article 2018 EN Gold
BACKGROUND: Tranexamic acid (TXA) is an antifibrinolytic agent that has shown promise in reducing blood loss during total hip arthroplasty (THA). Several studies have reported side effects of high-dose TXA administration, including myocardial infarction (MI), thromboembolic events, and seizures. These possible side effects have prevented the widespread adoption of TXA in the surgical community. ME…
29
Citations
96
References
13
Authors
2.06
FWCI
Citations by Year
Last 7 yearsTopics
Keywords
UN Sustainable Development Goals
1 SDGsAuthors & Affiliations
13 authors| # | Author | Institutions | ORCID |
|---|---|---|---|
| 1 | Nicoleta Stoicea Corresponding | Northwestern University (US) The Ohio State University Wexn… (US) +2 | |
| 2 | Kenneth R. Moran | — | |
| 3 | Mahmoud Abdel‐Rasoul | The Ohio State University (US) | |
| 4 | Andrew H. Glassman | The Ohio State University Wexn… (US) | |
| 5 | Thomas J. Ellis | Orthopedic One (US) | |
| 6 | John Ryan | The Ohio State University Wexn… (US) | — |
| 7 | Jeffrey F. Granger | The Ohio State University Wexn… (US) | — |
| 8 | Nicholas C. Joseph | — | |
| 9 | Nathan Salon | Northwestern University (US) | — |
| 10 | Wiebke Ackermann | — | — |
| 11 | Barbara Rogers | — | — |
| 12 | Weston L. Niermeyer | The Ohio State University (US) | |
| 13 | Sergio Daniel Bergese | The Ohio State University Wexn… (US) |
Related Works
10Data: OpenAlex